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Tityus serrulatus venom (TsV) consists of numerous peptides with different physiological and pharma-
cological activities. Studies have shown that scorpion venom increases pro-inﬂammatory cytokine
production, contributing to immunological imbalance, multiple organ dysfunction, and patient death.
We have previously demonstrated that TsV is a venom-associated molecular pattern (VAMP) recognized
by TLRs inducing intense inﬂammatory reaction through the production of pro-inﬂammatory cytokines
and arachidonic acid-derived lipid mediators prostaglandin (PG)E2 and leukotriene (LT)B4. Lipid bodies
(LBs) are potential sites for eicosanoid production by inﬂammatory cells. Moreover, recent studies have
shown that the peroxisome proliferator-activated receptor gamma (PPAR-g) is implicated in LB formation
and acts as an important modulator of lipid metabolism during inﬂammation. In this study, we used
murine macrophages to evaluate whether the LB formation induced by TsV after TLR recognition cor-
relates with lipid mediator generation by macrophages and if it occurs through PPAR-g activation. We
demonstrate that TsV acts through TLR2 and TLR4 stimulation and PPAR-g activation to induce LB for-
mation and generation of PGE2 and LTB4. Our data also show that PPAR-g negatively regulates the pro-
inﬂammatory NF-kB transcription factor. Based on these results, we suggest that during envenomation,
LBs constitute functional organelles for lipid mediator production through signaling pathways that
depend on cell surface and nuclear receptors. These ﬁndings point to the inﬂammatory mechanisms that
might also be triggered during human envenomation by TsV.
© 2014 Elsevier Ltd. All rights reserved.1. Introduction
Tityus serrulatus (Ts) scorpion causes severe envenomation,
specially in infants, who may be at increased risk of death (Amaralerleukin; TNF, tumor necrosis
d bodies; TLRs, Toll-like re-
n; DAMP, damage-associated
lar pattern; PPAR-g, peroxi-
hidonic acid.
4040-903, Ribeir~ao Preto, SP,
K.F. Zoccal), francisogarcia@
m (C.S. Bitencourt), sorgi@
rdon), ecabraga@fcfrp.usp.bret al., 1993). Venoms contain different components capable of
activating the immune system through enhanced production of
inﬂammatory mediators (Petricevich, 2010). Indeed, our group has
previously shown that Ts venom (TsV) and its toxins Ts1, Ts2, or Ts6
were able to induce the production of nitric oxide (NO), interleukin
(IL)-6, and tumor necrosis factor (TNF)-a by macrophages in vitro
(Zoccal et al., 2011). Besides cytokine production, we have also
shown that intraperitoneal injection of Ts2 and Ts6 in mice induced
the production of the arachidonic-acid derived inﬂammatory lipid
mediators prostaglandin (PG)E2 and leukotriene (LT)B4 (Zoccal
et al., 2013). The production of these pro-inﬂammatory mediators
involved the activation of MAPKs and NF-kB dependent pathways
through the recognition of Toll-like receptors 2 (TLR2) and 4 (TLR4),
and of CD14 (Zoccal et al., 2014). Therefore, we proposed the term
venom-associated molecular pattern (VAMP) to designate venom-
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munity (Zoccal et al., 2014).
LTs, PGs, thromboxanes, and lipoxins are a group of biologically
active oxygenated fatty acids known as eicosanoids. Eicosanoids
function as paracrine mediators of inﬂammation as well as intra-
cellular signals (Henderson, 1994; Simchowitz et al., 1994). PGE2
and LTB4 are AA-derived metabolites from pathways dependent on
cyclooxygenase 1 and 2 (COX-1 and COX-2) and 5-lipoxygenase (5-
LO), respectively (Funk, 2001; Samuelsson, 2000). Although the
enzymatic pathways for eicosanoid formation are well understood,
the intracellular sites of action of these enzymes and the cellular
sources of arachidonic acid remain less clear. Recent studies have
focused on the intracellular localization of eicosanoid forming en-
zymes. COXs are associated with cellular membranes, including the
endoplasmic reticulum and nuclear membrane (Morita et al., 1995;
Otto and Smith, 1994; Smith et al., 1996). In contrast, 5-LO has been
localized to the cytoplasm, the perinuclear membrane, and the
euchromatin within the nucleus, according to the cell and its state
of activation (Brock et al., 1994; Reid et al., 1990; Rouzer and
Kargman, 1988; Woods et al., 1995, 1993). While translocation
from cytosol to membranes may facilitate interactions of cytosolic
enzymes with membrane-bound arachidonate, there is increasing
evidence that speciﬁc compartmentalization of eicosanoid forma-
tionwithin cells may relate to the different autocrine and paracrine
functions of eicosanoids (Almeida et al., 2014; Bozza and Viola,
2010; Serhan et al., 1996; Sorgi et al., 2009). Lipid bodies (LBs)
may represent novel potential sites for paracrine eicosanoid pro-
duction within inﬂammatory cells.
LBs are intracellular lipid organelles, found in different cell
types, including macrophages, which participate in lipid meta-
bolism, inﬂammatory mediator production, membrane trafﬁcking,
and intracellular signaling (Bozza et al., 2007; Martin and Parton,
2006). LBs have emerged as compartmentalization sites for the
metabolism of lipid mediators, especially in inﬂammatory and in-
fectious conditions (Bozza et al., 2011; Pacheco et al., 2002; Vieira-
de-Abreu et al., 2005). Studies have showed that increased amounts
of LB correlated with the increased release of LTB4, LTC4, and PGE2
by leukocytes activated with the calcium ionophore A23187
(Bandeira-Melo et al., 2001; Bozza et al., 1996, 1997a, 1997b;
Pacheco et al., 2002). Moreover, our group has previously shown
that LB formation induced by Histoplasma capsulatum is associated
with LTB4 and PGE2 production (Sorgi et al., 2009). However, the
potential role of LBs as sites for lipid mediator production induced
by TsV has not yet been addressed.
Distinct signaling pathways have been suggested to be involved
in LB formation, including those that operate downstream of TLRs.
LB formation has been shown to be dependent on TLR2/TLR6 in
Mycobacterium leprae-infected macrophages (de Mattos et al.,
2012), or on CD36/TLR2 and peroxisome proliferator-activated re-
ceptor gamma (PPAR-g) in Mycobacterium bovis bacillus Calmette
Guerin (BCG) infection (Almeida et al., 2014). PPARs are lipid-
activated transcription factors that are ligand dependent. These
receptors regulate target gene expression by binding to speciﬁc
peroxisome proliferator responsive elements located in the regu-
latory sites of each gene. Agonists alter and stabilize the confor-
mation of PPAR-g, creating a binding site, with subsequent
recruitment of transcriptional co-activators, resulting in increased
target gene transcription. PPAR-g, speciﬁcally, has been shown to
function as a key transcriptional regulator of cell differentiation,
inﬂammation, and lipid metabolism in macrophages and dendritic
cells (Szatmari and Nagy, 2008). In Mycobacterium infection, the
PPAR-g role in the regulation of lipid metabolism, lipid body for-
mation, and immune response has been well established (Almeida
et al., 2012, 2009; de Mattos et al., 2012; Mahajan et al., 2012;
Rajaram et al., 2010).Considering the research ﬁndings detailed above, we hypothe-
sized that PPAR-g activation is involved in LB formation and conse-
quently in lipid mediator production by macrophages in response to
TsV-induced TLR stimulation. We showed here that LB formation
induced by TsV correlates with enhanced lipid mediator generation
by macrophages. We also showed that TsV-elicited LB formation and
lipid mediators production are TLR4, TLR2 and PPAR-g dependent.
2. Materials and methods
2.1. Animals
TLR2 and TLR4 knockout (KO or /) mice, from 6 to 8 weeks,
were donated by S. Akira (Osaka University, Osaka, Japan) and bred
in the Animal House of the Faculdade deMedicina de Ribeir~ao Preto
(Universidade de S~ao Paulo, Ribeir~ao Preto, Brazil). Strain-matched
wild type (WT) C57Bl/6 (C57Bl/6 was the genetic background for
the TLR2/ and TLR4/ animals) mice of both sexes were bred in
the Faculdade de Cie^ncias Farmace^uticas de Ribeir~ao Preto (Uni-
versidade de S~ao Paulo, Ribeir~ao Preto, Brazil). Mice were main-
tained at 25 C, with a 12 h light/dark cycle, and with free access to
food and water. The experimental protocols were approved by the
Animal Care Committee of the Prefeitura of the Campus of Ribeir~ao
Preto (PCARP) at Universidade de S~ao Paulo, Ribeir~ao Preto, Brazil
(Protocol number 11.1.160.53.1).
2.2. Tityus serrulatus venom
TsV was extracted from T. serrulatus scorpion as previously
described (Arantes et al., 1989), desiccated, and stored at 20 C.
Prior to the experiments, TsV was diluted in phosphate buffered
saline (PBS) and ﬁltered through sterilizing membranes (Spritzen-
ﬁlter: 0.22 mm, TPP, Switzerland). The Limulus Amoebocyte Lysate
test (LAL) (QCL-1000, Bio Whittaker, Cambrex Company, Walkers-
ville, MD, USA) was performed to detect LPS in TsV samples, ac-
cording to the manufacturer's instructions.
2.3. Investigation of PPAR-g participation in LB formation and lipid
mediator release
Leukocytes were isolated from the peritoneal cavities of C57Bl/6,
TLR2/ or TLR4/ mice by lavage with 3 mL of RPMI incomplete
medium. After centrifugation at 400 g, the cells were plated in 8-
well micro culture slides (BD Bioscience) at a density of
2  105 cells/well in RPMI medium supplemented with 10 mM L-
glutamine, 100 U/ml penicillin, 100 U/ml streptomycin, and 10%
fetal bovine serum (FBS). Cells were cultured at 37 C in a humid-
iﬁed 5% CO2 atmosphere for 18 h. After washing with sterile PBS,
adherent cells (macrophages) were pretreated or not with PPAR-g
receptor antagonist (GW9662, 10 mM, Cayman Chemical, USA) in
fetal bovine serum (FBS)-free RPMI for 30 min and stimulated or
not with TsV (50 mg/mL) for 0.5, 4 or 24 h at 37 C in a 5% CO2 at-
mosphere. After stimulation, cell free supernatants were harvested
and stored at20 C for cytokine quantiﬁcation (item 2.4) and cells
were prepared for LB evaluation (item 2.5) or to maximal PGE2 and
LTB4 release (item 2.6). For quantiﬁcation of lipid mediators,
adherent macrophages were suspended in Ca2þMg2þ HBSS and
stimulated for 15 min with 0.5 mM calcium ionophore A23187
(SigmaeAldrich).
2.4. Cytokine measurements
Cell free supernatants of adherent macrophages from C57Bl/6
mice pretreated or not with GW9662 for 30 min and stimulated or
not with TsV (50 mg/mL) for 24 h were collected and concentrations
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sorbent assays (ELISA), according to the manufacturer's in-
structions (R&D Systems, Minneapolis, USA). The optical densities
were measured at 405 nm in a microplate reader (mQuant, Biotek
Instruments Inc.). The sensitivities were >10 pg/mL.
2.5. LB staining and quantiﬁcation
Macrophages adhered to slides were ﬁxed in 3.7% formaldehyde
in Caþ2/Mgþ2-free HBSS (pH 7.4), rinsed in 0.1 M cacodylate buffer
(pH 7.4), and stained in 1.5% osmium tetroxide (30min). After being
rinsed in water, cells were immersed in 1.0% thiocarbohydrazide
(5 min), rinsed in water and then in 0.1 M cacodylate buffer, incu-
bated in 1.5% osmium tetroxide (3 min), rinsed in distilled water,
dried, and mounted in slides for further analysis. The morphology
of ﬁxed cells was observed, and LBs were quantiﬁed by light mi-
croscopy with a 100 objective lens in 150 leukocytes that were
stimulated in triplicate (50 consecutive leukocytes were analyzed
in each slide). Blind observers performed LB quantiﬁcation.
2.6. LTB4 and PGE2 measurements
LTB4 andPGE2 concentrations in the supernatantswere assayedby
a speciﬁc enzyme immunoassay (Cayman Chemical, USA), according
to themanufacturer's instructions. Sample absorbancewasmeasured
at 420 nm in a microplate reader (mQuant, Biotek Instruments Inc.),
and the concentrations of eicosanoids were calculated based on the
standard curve. The detection limit was >13 pg/mL.
2.7. NF-kB reporter assay
RAW-Blue™ cells, RAW264.7 macrophages that stably express
the secreted embryonic alkaline phosphatase (SEAP) gene, which is
inducible by the NF-kB/AP-1 transcription factors and are resistant
to the selectable marker Zeocin, were donated by Dr. Huy Ong
(Universite de Montreal, Canada). The cells were seeded in 96-well
micro culture plates at a density of 2  105 cells/well in DMEM
supplemented with Normocin™ (50 mg/mL) and cultured at 37 C
in a humidiﬁed 5% CO2 atmosphere for 18 h. After this period, the
cells were incubated with the PPAR-g antagonist (GW9662, 10 mM,
Cayman Chemical, USA) or with the PPAR-g agonist Roziglitazone
(Rz, 80 mM, Cayman Chemical, USA) for 30 min and then stimulated
with TsV (50 mg/mL) for 24 h. After this period, the medium was
collected, and 50 mL samples were mixed, in 96-well plates at 37 C
for 2 h, with 150 mL of QUANTI-Blue™ (InvivoGen, USA), which is a
SEAP detection medium. The optical density was then measured at
650 nm using an ELISA reader (mQuant, Biotek Instruments Inc.).
2.8. Gene expression analysis by real-time PCR (qRT-PCR)
Macrophage mRNA expression was evaluated by qRT-PCR after
0.5, 4, and 24 h of stimulation with TsV. mRNA was isolated using
the RNeasy Mini kit (Qiagen Inc., Valencia, CA), according to the
manufacturer's instructions. cDNA (complementary DNA) was
synthesized from 200 ng of total RNA using random primers (High
Capacity cDNA Reverse Transcription Kit, Applied Biosystems,
Temecula, CA). Aliquots of 2 ml of total cDNAwere ampliﬁed by qRT-
PCR (StepOne Plus, Applied Biosystems) using the primers and
probe for Pparg (Mm01184322) (TaqMan® Gene Expression Assay,
Applied Biosystems). Gapdh (Mm99999915) and Actb
(Mm00607939) were used as reference genes. Ampliﬁcation was
performed under the following conditions: denaturation at 95 C
for 10 min; followed by 40 cycles at 95 C for 15 s, and 60 C for
1 min. Relative quantiﬁcation was performed using the DDCt
Method.2.9. Statistical analysis
Data are expressed as means ± SEM and were analyzed using
one-way ANOVA. p < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. TsV induces LB formation, and LTB4 and PGE2 production in
macrophages
Based on our previous results showing that 50 mg/mL of TsV did
not affect peritoneal macrophage viability (Zoccal et al., 2014), we
used this same concentration for cell stimulation. We ﬁrst inves-
tigated the TsV capacity to induce LB formation in peritoneal
macrophages. As shown in Fig. 1(A), TsV increased LB formation in
peritoneal macrophages after 0.5, 4, and 24 h of stimulation.
Because LBs are specialized organelles involved in ampliﬁcation of
lipid mediator synthesis (Bozza and Viola, 2010) we next investi-
gated whether the increased numbers of LBs in TsV-stimulated
macrophages would correlate with increased LTB4 and PGE2 pro-
duction by these cells. Indeed, macrophages exposed to TsV and
stimulated with the calcium ionophore A23187 increased LTB4
production in a pattern that very closely matched LB formation
(Fig. 1(B)). PGE2 production also increased at all time points
compared to non-stimulated controls, albeit with a different
pattern (Fig. 1(C)). These results indicate that LBs are important for
lipid mediator generation during envenomation.
3.2. TsV induces LB formation through PPAR-g via, TLR2 and TLR4
Because TLRs have been implicated in LB formation (Sorgi et al.,
2009), we used peritoneal macrophages from TLR2/ and TLR4/
mice to investigate the role of these TLRs in LB formation. We
observed decreased LB formation in TLR2-deﬁcient macrophages
stimulated with TsV for 0.5, 4, and 24 h, and in TLR4-deﬁcient
macrophages after 0.5 and 4 h of stimulation (Fig. 2(A)). Given
the involvement of the transcription factor PPAR-g in LB formation
through TLR2 recognition (Almeida et al., 2014), our next step was
to evaluate Pparg expression in TsV-stimulated macrophages. qRT-
PCR analysis revealed that TsV up-regulated Pparg mRNA expres-
sion at 4 and 24 h stimulation (Fig. 2(B)). We also evaluated Pparg
expression in TLR2 and TLR4 deﬁcient macrophages by qRT-PCR
after 24 h of TsV stimulation. TsV up-regulated the expression
levels of Pparg in macrophages from C57Bl/6 mice, whereas in cells
from TLR2/ and TLR4/mice up-regulation also occurred but to
a signiﬁcantly lower extent (Fig. 2(C)). To further investigate the
role of PPAR-g in LB formation, we pretreated macrophages with
the PPAR-g antagonist GW9662 and then stimulated the cells with
TsV. LB formation in cells treated with GW9662 after 4 and 24 h of
TsV stimulation was not signiﬁcantly greater than in non-TsV-
stimulated controls (Fig. 2(D)). Altogether, these results indicate
that TLR2, TLR4, and PPAR-g regulate LB formation in TsV-
stimulated macrophages.
3.3. PPAR-g activation inhibits NF-kB in TsV-stimulated
macrophages
To conﬁrm that PPAR-g also serves as a negative regulator of
macrophage differentiation and activation through transrepression
of the transcription factors (Ricote et al., 1998), we investigated NF-
kB expression in TsV-stimulated cells pretreated with a PPAR-g
antagonist or an agonist. Our data show that the PPAR-g agonist Rz
signiﬁcantly inhibits NF-kB activation (Fig. 3). Rz has the potential
to exert biological activities independent of PPAR-g activation (Neri
et al., 2011), thus we sought to conﬁrm the role of PPAR-g activation
Fig. 1. TsV induces lipid body formation and PGE2 and LTB4 production. Adherent macrophages from C57Bl/6 mice were stimulated with TsV (50 mg/mL) for 0.5, 4, and 24 h. Non-
stimulated cells were used as control. Cells were stained with osmium tetroxide for LB analysis (A), or stimulated for 15 min with A23187 (0.5 mM) for quantiﬁcation of LTB4 (B) and
PGE2 (C). Results are expressed as means ± SEM (n ¼ 4), and are from 3 independent experiments (n ¼ 12). LBs per cell were enumerated by light microscopy analysis with a 100
objective lens. *p < 0.05 (one-way ANOVA) compared to control (dashed line).
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the speciﬁc PPAR-g inhibitor GW9662. The inhibitory effects were
reverted by the speciﬁc antagonist demonstrating the negative role
of PPAR-g in NF-kB activation (Fig. 3).Fig. 2. Lipid body formation induced by TsV involves TLR4 and TLR2 recognition and PP
were stimulated with TsV (50 mg/mL) for 0.5, 4, and 24 h. LBs were counted in peritoneal
(n ¼ 3), and were obtained from 2 independent experiments (n ¼ 6). *p < 0.05 (one-way AN
(WT) mice were treated with TsV (50 mg/mL) for 0.5, 4 or 24 h (B) and cells from TLR2/ o
were used as the negative control. Cells were lysed, and total RNA was extracted. qRT-PCR w
Results were normalized to the expression levels of the reference genes Actb and Gapdh. Th
followed by Dunnett's post-test) compared to control. Differences were considered statist
pretreated or not with the PPAR-g antagonist GW9662 (10 mM) 30 min before stimulation
control. LBs per cell were enumerated by light microscopy analysis with a 100 objective len
experiments (n ¼ 8). *p < 0.05 (one-way ANOVA) compared to control and #p < 0.05 comp3.4. PPAR-g is involved in LTB4 and PGE2 production by TsV-
stimulated macrophages
We previously demonstrated, in vitro, that PGE2 and LTB4 are
produced upon TsV stimulation of macrophages (Zoccal et al.,AR-g expression. (A) Peritoneal macrophages from C57Bl/6, TLR2/ or TLR4/ mice
macrophages after osmium tetroxide staining. Results are expressed as means ± SEM
OVA) compared to medium alone (dashed line). Adherent macrophages from C57Bl/6
r TLR4/ were treated with TsV (50 mg/mL) for 24 h (C). Non-stimulated macrophages
as performed to determine the relative expression levels of transcripts encoding Pparg.
e DDCt method was used for the analysis of qRT-PCR data. *p < 0.05 (one-way ANOVA
ically signiﬁcant when p < 0.05. (D) Adherent macrophages from C57Bl/6 mice were
with TsV (50 mg/mL) for 4 and 24 h. Non-stimulated cells were used as the negative
s. Results are expressed as means ± SEM (n ¼ 4), and were obtained from 2 independent
ared to TsV.
Fig. 3. Activation of NF-kB/AP-1 in RAW-Blue™ cells. These cells were derived from
RAW 264.7 macrophages and contain a secreted embryonic alkaline phosphatase
(SEAP) reporter construct that is integrated into the cellular DNA and that can be
induced by NF-kB. The cells were incubated with PPAR-g antagonist (GW9662, 10 mM)
or with PPAR-g agonist (Rz, 80 mM) for 30 min and then stimulated with TsV (50 mg/
mL) for 24 h. After 24 h of stimulation, the QUANTI-Blue™ substrate was used to
measure the SEAP at 650 nm with an ELISA reader. *p < 0.05 (one-way ANOVA)
compared to non-stimulated cells; #p < 0.05 compared to TsV. Results are expressed as
means ± SEM (n ¼ 4) and were obtained from 2 independent experiments (n ¼ 8).
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TsV stimulation plus calcium ionophore A23187 is TLR2 and TLR4
dependent, we quantiﬁed LTB4 in stimulated and non-stimulated
macrophages from TLR2/ or TLR4/ mice. For this, peritonealFig. 4. PPAR-g acts as a key modulator of lipid metabolism. Adherent macrophages from
with TsV (50 mg/mL) for 4 and 24 h. Unstimulated macrophages were used as the negative co
of LTB4 (A) and PGE2 (B) production *p < 0.05 (one-way ANOVA) compared to non-stimulate
mL) for 24 h, and IL-6 (C), IL-1b (D), and KC (E) production was measured by ELISA. Result
periments (n ¼ 8). *p < 0.05 (one-way ANOVA) compared to non-stimulated cells.macrophages were stimulated with TsV or not for 4 h. After this
period, adherent macrophages were suspended in Ca2þMg2þ HBSS
and stimulated with calcium ionophore A23187. TsV-induced LTB4
production was totally impaired in TLR2/ and TLR4/ cells
(Fig. Supplementary 1). This result is similar to our previous study
(Zoccal et al., 2014), however the magnitude is different, demon-
strating that, in the presence of the calcium ionophore, lipid me-
diators production is enhanced. We next investigated the
involvement of PPAR-g in LTB4 and PGE2 production in response to
TsV stimulation. Pretreatment of macrophages with GW9662
signiﬁcantly inhibited the production of these lipid mediators
(Fig. 4(A) and (B), respectively). On the other hand, GW9662 did not
affect the production of protein inﬂammatory mediators IL-6, IL-1b,
and KC induced by TsV (Fig. 4(C)e(E), respectively). Our results
indicate that PPAR-g signaling pathways are activated upon TsV
recognition through TLRs and play an important role in LB forma-
tion and lipid mediator production.
4. Discussion
In this study, we show that TsV recognition through TLR2 and
TLR4 activates PPAR-g to regulate LB formation, as well as lipid
metabolism in macrophages, indicating that PGE2 and LTB4 gener-
ation during envenomation is dependent on LB formation.
Inﬂammatory mediators are released when pathogen-
associated molecular patterns (PAMPs), damage-associated mo-
lecular patterns (DAMPs) or more recently VAMP are recognized by
pattern recognition receptors (PRRs) in immune cells (Murray and
Wynn, 2011; O'Neill and Bowie, 2007; Yang et al., 2013; Zoccal et al.,C57Bl/6 mice were pretreated or not with GW9662 (10 mM) 30 min before stimulation
ntrol. Macrophages were stimulated for 15 min with A23187 (0.5 mM) for quantiﬁcation
d cells and #p < 0.05 compared to TsV. Adherent cells were stimulated with TsV (50 mg/
s are expressed as means ± SEM (n ¼ 4), and were obtained from 2 independent ex-
Fig. 5. TsV recognition through TLR4/TLR2 results in PPAR-g and NF-kB activation.
TsV-induced production of inﬂammatory mediators by macrophages can occur in two
ways: (1) TsV induces NF-kB activation that results in inﬂammatory mediator release,
or (2) TsV induces PPAR-g activation that results in LB formation and, consequently, in
increased PGE2 and LTB4 production. Interestingly, TsV-induced PPAR-g activation
suppress NF-kB signaling pathway.
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phage LB formation induced by H. capsulatum infection (Sorgi et al.,
2009). Likewise, LB formation in LPS-stimulated macrophages has
been shown to be dependent on TLR4 (Pacheco et al., 2002).
Therefore, to clarify the role of PRR in TsV-induced LB formation, we
investigated the possible participation of TLR. LB formation was
impaired in TLR2/ and TLR4/ macrophages, indicating an
important role for these receptors in the LB biogenesis pathway.We
speculate that TsV-induced LB formation occurs through either: (1)
direct interactions between the venom and cell receptors, or (2) an
indirect mechanism mediated by venom-induced cytokines and
chemokines.
Our results suggest that LB formation through TLR2/TLR4
signaling might be important to LTB4 production, whereas PGE2
production has previously been shown to depend on TLR4 but not
TLR2 (Zoccal et al., 2014). Our previous study demonstrated that
TsV per se induces lipid mediators (Zoccal et al., 2014) and we
conﬁrmed that here using a calcium ionophore as an unspeciﬁc
stimulus known to potentiate lipid mediator release by cells (Rao
et al., 1993). Here, we also show that TsV-induced cell signaling
generates lipid mediators in LB-dependent manner. However, other
mechanisms might be involved in venom recognition to induce
lipid mediators, thus, other cellular activation pathways, and the
correlation between lipid mediator production and LB formation
still require further elucidation.
Besides lipid storage and metabolism, LBs may function in
membrane trafﬁcking and cell signaling (Fujimoto et al., 2004; Liu
et al., 2004; Wan et al., 2007), and in compartmentalization of
different classes of proteins, such as caveolin, proteins of the Rab
family (Liu et al., 2004; Martin et al., 2005; Pol et al., 2004; Wan
et al., 2007), eicosanoid-forming enzymes (Bozza et al., 1998;
Pacheco et al., 2002), and protein kinases like PI3 kinase, MAP ki-
nase, and PKC (Chen et al., 2002; Yu et al., 1998, 2000). Studies have
shown that LB biogenesis is strictly controlled (Bozza et al., 2007).
PKC, PI3K, ERK1/2, and iPLA2 signaling pathways have been
implicated in LB formation induced by Lys49 phospholipase A2
from Bothrops asper snake venom (Giannotti et al., 2013). Our re-
sults indicate that PPAR-g is involved in TsV-induced LB formation
and PGE2 and LTB4 production by macrophages, which were
inhibited by the PPAR-g antagonist. These results agree with those
of a previous study that showed that a PPAR-g antagonist inhibited
LB biogenesis inM. bovis BCG-infectedmacrophages (Almeida et al.,
2014). On the other hand, PGE2 release by GM-CSF-primed bone
marrow-derived macrophages has been shown to be independent
of PPAR-g activation, but dependent on TLR2 and its co-receptors
TLR1, TLR6, and CD14, as well as on MyD88 and NF-kB (Almeida
et al., 2012; Sorgi et al., 2012). PPAR-g expression in macrophages
infected with BCG or stimulated with ManLAM is dependent on
TLR2 signaling (Almeida et al., 2009). However, the nonpathogenic
Mycobacterium smegmatis, a well-known TLR2 ligand, and the
synthetic TLR2 ligand Pam3Cys fail to induce PPAR-g expression in
macrophages (Almeida et al., 2009; Rajaram et al., 2010), suggest-
ing that co-receptors of TLR2 are required to induce PPAR-g
expression. We know that PPAR-g also serves as a negative regu-
lator of macrophage activation, altering the expression of several
inﬂammatory genes (Jiang et al., 1998; Ricote et al., 1998), modu-
lating macrophage differentiation and activation through trans-
repression of the transcription factors STAT, AP-1, and NF-kB (Ricote
et al., 1998), and attenuating the respiratory burst (Von Knethen
and Brune, 2002).
Altogether, our results suggest a central role for LBs as
compartmentalization sites for lipid mediator generation in cells
involved in envenomation. Considering our previous results (Zoccal
et al., 2014) and those obtained in this study, we propose amodel in
which TsV recognition through macrophage TLR4/TLR2 activatesNF-kB and/or PPAR-g. PPAR-g activation by TsV would result in LB
formation, PGE2 and LTB4 production, while NF-kB activationwould
result in pro-inﬂammatory cytokine production (Fig. 5). We hy-
pothesize that according to the stimuli, LBs compartmentalize
different sets of proteins and their metabolic products can lead
either to pro-inﬂammatory ampliﬁcation or to down-modulation of
leukocyte functions. This model is consistent with a previous study
showing that in mycobacterial infection, PPAR-g activation can
negatively modulate NF-kB activation, inhibiting the production of
pro-inﬂammatory cytokines bymacrophages (Almeida et al., 2012).
Although PPAR-g downstream effectors and target genes activated
by TsV remain to be elucidated, PPAR-g can be considered an
attractive target candidate for therapeutic intervention strategies
that is able to diminish the damage caused by T. serrulatus venom.
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